Prollenium Medical Technologies Inc. Acquires Rights to Distribute Alyria Skincare

AURORA, ON, Sept. 25, 2014 /CNW/ - Prollenium Medical Technologies Inc., a Canadian company based out of Aurora, Ontario, has acquired the rights to distribute the complete Alyria Skin Optimizing System in Canada. As of September 22^nd, the prestige skincare line was transferred over to Prollenium for marketing and distribution.

The Alyria skincare line is comprised of more than 20 products for healthy and beautiful looking skin. These include, but are not limited to cleansers, moisturizes, and anti-aging serums for all skin types. Much like Prollenium's flagship brand Revanesse (hyaluronic acid dermal fillers), the Alyria line is manufactured in Canada. "We are extremely excited to expand our Canadian-made line of products. We are proud to produce and sell products that are safe, effective and made in our home country," says the Managing Director of Prollenium, Ario Khoshbin.

Alyria skincare is available exclusively through physicians. All orders should be placed with the Prollenium Customer Service department using the following methods:

• Phone at 1-866-5ALYRIA (525-9742) or 1-866-353-3015
• Fax at 1-888-351-5976
• Email at [email protected]

For any questions relating to Alyria, please contact the Prollenium Customer Service department at 1-866-5ALYRIA (525-9742).

For more information, please visit www.alyria-med.com or www.prollenium.com.

Prollenium Medical Technologies Inc., founded in 2002, is dedicated to the research, design, manufacture and distribution of implantable polymers in the pharmaceutical/dermatological industry. The company is committed to providing innovative products worldwide that are safe and viable. Flagship product lines include Revanesse^® Hyaluronic Acid Dermal Fillers and Phiderma^® Anti-Aging Skincare.

SOURCE: Prollenium Medical Technologies Inc.

Brittany Edwards, Phone: [phone], Email: [email protected]